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Received 27 September 2015; Accepted 20 July 2016
Academic Editor: Bruno Gagnon
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Background. In order to better design awareness programs on chronic pain (CP), measurement of knowledge, beliefs, and attitudes
of people in the community towards this condition is most useful. Objectives. To develop and validate a French-Canadian scale
that could be used for this purpose. Methods. Items of the Chronic Pain Myth Scale (CPMS) were developed based on different
information sources, reviewed by pain experts, and pretested. The CPMS was administered to 1555 participants among the general
Quebec population. Results. The final CPMS contained 26 items allowing the calculation of three subscales scores (knowledge,
beliefs, and attitudes towards people suffering fromCP, biopsychosocial impacts ofCP, and treatment ofCP)which showed adequate
internal consistency (𝛼 = 0.72–0.82). There were statistically significant differences in subscales scores between participants who
reported suffering versus not suffering fromCP, reported knowing versus not knowing someone who suffers fromCP, and reported
being versus not being a healthcare professional, which supports the construct validity of the scale.Conclusions. Our results provide
preliminary evidence supporting the psychometric qualities of the use of the CPMS for themeasurement of knowledge, beliefs, and
attitudes towards CP among French-speaking individuals of the Quebec general population.
1. Introduction
Chronic pain (CP) affects approximately 11 to 29%of the adult
Canadian population [1–5] and has major impacts on the
physical functioning, themental health, and the quality of life
of those suffering from it [6–9]. It also constitutes an impor-
tant economic burden as much for the patients as for the
healthcare system and the different third-party payers [10, 11].
It is well documented that CP is commonly underre-
ported, underrecognized, and underdiagnosed in clinical
practice and in the community [12–16]. Its treatment remains
suboptimal, mainly because of insufficient training of health-
care professionals, limited access to specialized pain clinics,
suboptimal use or efficacy of treatment modalities, and lack
of recognition of this condition [6, 13, 14, 16–18]. Heightened
awareness coupled to better education about this condition
for the healthcare professionals, the patients, and the general
public is an important but a still neglected aspect in the efforts
to improve CP management [17, 19]. Indeed, it is not rare to
hear pain clinicians and researchersmentioning that negative
beliefs and prejudices towards CP are still common in the
community. In fact, several studies reported on stigmatiza-
tion of patients suffering from CP and lack of empathy from
the community, including healthcare professionals [20–22].
In order to better design and tailor awareness and
education programs about CP, its impacts, and the ways to
prevent/manage it, measurement of knowledge, beliefs, and
attitudes of the general population towards this condition
is most useful. However, available validated measurement
scales have been originally designed for specific populations
such as healthcare professionals [23–30] or patients suffering
from different pain conditions [31–39], and none of them
were intended for broader use in persons in the community
irrespective of their background. In fact, scales designed to be
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used among healthcare professionals or patients sometimes
asked about aspects that are specific to their biomedical
expertise or condition (e.g., pain diagnosis, drug prescription,
specific impacts of pain treatments, available scientific data,
and how patients view or cope with their own symptoms).
Although some of the available scales originally designed for
patients have been used in pain-free subjects [35, 37, 40],
some common misbeliefs towards people suffering from CP
that are often heard in the community did not seem well cov-
ered. Other scales were validated in the general population,
but only applicable to a specific type of CP (e.g., back pain)
[39].
This study thus aimed at developing a French-Canadian
scale that could be used to measure knowledge, beliefs, and
attitudes that people in the community have towards CP. Our
a priori hypothesis was that the CPMS would measure three
constructs of knowledge, beliefs, and attitudes, that is, those
towards people suffering fromCP, biopsychosocial impacts of
CP, and treatment of CP.The internal structure, internal con-
sistency, and construct validity of the use of this scale named
the Chronic Pain Myth Scale (CPMS) were also examined.
2. Methods
2.1. Development of the Chronic Pain Myth Scale. The CPMS
was designed with the intent of providing a generic “one
fits all” measurement tool that gives an overall index of the
knowledge, beliefs, and attitudes that people have towards
CP. It was developed through a multistep process according
to a number of recommendations for the development of
health measurement scales [41]. Preliminary items about
knowledge, beliefs, and attitudes towards people suffering
from CP, its biopsychosocial impacts, and its treatment were
derived from different information sources. First, an email
consultation was conducted among various key informants
and pain experts, including 1 patient suffering from CP, 1
primary care nurse practitioner, 4 researchers in the field of
pain, and 7 clinician-researchers in the field of pain (1 family
physician, 2 anesthesiologists, 1 nurse, 1 dentist, 1 pharmacist,
and 1 psychologist).These informants were chosen according
to purposive sampling and asked to list negative beliefs and
prejudices towards CP that are common in the community.
Second, a comprehensive literature search was conducted
to identify and review existing validated scales designed to
measure knowledge, beliefs, attitudes, and perceptions about
pain, that is, Back Beliefs Questionnaire (BBQ) [38, 39],
Beliefs about Pain Control Questionnaire (BPCQ) [37],
Health Care Providers’ Pain and Impairment Relationship
Scale (HC-PAIRS) [24], Knowledge and Attitudes Survey
Regarding Pain (KASRP) [25], KnowPain-50 (KP-50) [23,
27], Pain and Impairment Relationship Scale (PAIRS) [36],
Pain Attitudes and Beliefs Scale (PABS) [26, 29], Pain Beliefs
and Perceptions Inventory (PBPI) [31, 32], Pain Beliefs Ques-
tionnaire (PBQ) [35], Pain Knowledge and Attitude (PAK)
[28], Survey of Pain Attitudes (SOPA) [33, 34], and Toronto
Pain Management Inventory (TPMI) [30]. Because most
of these scales were originally designed for very specific
populations (healthcare professionals, patients suffering from
CP), many items had to be adapted for broader use in
the community irrespective of the person’s background.
Finally, many educational and patient awareness websites,
leaflets, and publications in mass media about CP were
reviewed. Triangulation of these various data sources was
achieved to develop a preliminary list of items as comprehen-
sive as possible.
For the development of the CPMS, we avoided distin-
guishing between items measuring knowledge and those
measuring attitudes, as suggested by the authors of the
Knowledge and Attitudes Survey Regarding Pain (KASRP)
[25]. A total of 51 preliminary items were formulated in state-
ments that were then grouped into three categories depend-
ing on whether they were referring to knowledge, beliefs, and
attitudes towards (1) people suffering from CP, (2) biopsy-
chosocial impacts of CP, and (3) treatment of CP. Particular
attention was paid to avoid unnecessary content duplication
across items. Agreement with each statement was measured
with a Likert scale, as it is the case in most of the tools (10/12)
mentioned above. A 5-point Likert scale was chosen, ranging
from 1 (completely disagree) to 5 (completely agree). The list
of preliminary items was then reviewed by a convenience
sample of 14 pain experts who attended the Annual Meeting
of the Quebec Pain Research Network (http://www.qprn.ca/)
(January 2014). These individuals received the paper-and-
pencil questionnaire in their meeting package, including a
cover letter asking them to annotate their suggestions about
the clarity of the questionnaire, the formulation of the items,
and the items to be removed/added.Theywere then invited to
drop their responses at the front desk (14 out of 44 attendees
provided their suggestions). Item reduction and reformula-
tion were carried out by members of the study team based on
the minor comments that were received (e.g., removal of few
items, wording). The only major suggestion was to reverse
the formulation of items (i.e., having to agree with some
items and disagree with other items) in order to reduce
acquiescence bias (yea-saying) [41, 42], which was done. The
CPMS was then computerized on the web and pretested in a
purposive sample of 4 individuals from the community hav-
ing various socioeconomic status to ensure adequate compre-
hension of the items.The version of the CPMS to be validated
had 44 items.
2.2. Validation Study Design and Settings. The validity of the
use of the CPMS was evaluated in the context of a web-based
cross-sectional study launched among the general population
of the province of Quebec (Canada) between May and June
2014. Participants were eligible in this study if they were
French-speaking Quebec residents, were aged 18 and older,
and consented to complete the online questionnaire. Par-
ticipants who did not complete all the items of the CPMS
were excluded from the present validation study. The study
was approved by the Comité d’Éthique de la Recherche avec
des Êtres Humains de l’Université du Québec en Abitibi-
Témiscamingue (February 21, 2014).
2.3. Procedure. The SurveyMonkey Gold software (which
allows for the direct transfer of survey data into IBM SPSS
Statistics) was used to put the study questionnaire online
and collect data.The invitation to complete the questionnaire
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was disseminated using various diffusion platforms in order
to reach a large number of individuals from all over the
province and maximize our sample diversity and representa-
tiveness: (1) organizations that freely accepted to advertise the
study invitation on their website, via their members’ mailing
list, or during their scheduled activities, (2) social media such
as Facebook and Twitter, (3) paid publicity in provincial-
wide mass media (ads in newspapers and e-papers), and (4)
emails sent by the study team to research networks in the
province of Quebec, colleagues, and contacts. The launching
of this study also attracted media attention and was covered
in numerous regional broadcasts and text interviews (Radio
Canada, RNC Media, and Quebecor Media). For all dif-
fusion platforms, the invitation contained the questionnaire
hyperlink (electronic invitations) or URL (paper ads). Poten-
tial participants were invited to go on the online introduction
page of the study where enough information was provided to
insure informed consent before the beginning of the ques-
tionnaire.The online questionnaire was available for a period
of six weeks (May 1 and June 11, 2014).
In order to maximize participation rate, 10 prizes con-
sisting of prepaid VISA gift cards of Can$200 each were
drawn from all participants who had completed the online
questionnaire. A number of elements helped minimize dou-
ble participation: (1) responses were limited to only one IP
address, (2) responders were informed that only one partici-
pation per person was accepted, and (3) when it was time for
participants to write at the end of the questionnaire their
contact information in order to participate in the draw, those
tempted to provide a false identity were discouraged by a
statement explaining that prize winners will be asked to pro-
vide a copy of a valid piece of identification. Finally, careful
attention was given to duplication of first and last name, tele-
phone number, postal address, and email address during the
database cleaning process.
In addition to the 44 items of the CPMS to be validated,
the online questionnaire contained various items to assess
the responders’ sociodemographic characteristics (age, sex,
country of birth, work status, education level, and region
of residence). Participants were also asked if (1) they were
suffering from pain every day or repeatedly for more than
three months (i.e., considered as CP), if they knew someone
who hasCP, and (3) if theywere a healthcare professional (i.e.,
physician, nurse, physiotherapist, psychologist, or pharma-
cist, the first four ones being identified by the International
Association for the Study of Pain as clinicians who should
ideally be implicated in multidisciplinary pain management)
[43].
2.4. Data Analysis. Descriptive statistics were calculated to
depict the participants’ characteristics. Regarding CPMS’s
items, high values on positively worded items indicated better
knowledge and more positive beliefs and attitudes towards
people suffering fromCP, biopsychosocial impacts of CP, and
treatment of CP. Scores on negatively worded items were
reversed so that a high value also indicated better perceptions.
Using a principal axis factor extraction method (which is
recommendedwhen the data violate the assumption ofmulti-
variate normality) and an orthogonal Varimax rotation [44],
exploratory factor analysis was used to explore the CPMS
internal structure and to reduce the number of items for
the final version. Calculation of the CPMS subscales derived
from the exploratory factor analysiswas conducted as follows.
The scores of the three subscales of the CPMS were obtained
by summing the items clustered during the exploratory factor
analysis (see the appendix for the final version of the CPMS
and calculation method). Unstandardized Cronbach’s alpha
coefficients (𝛼) were used to assess the internal consistency
of the three CPMS subscales. These coefficients measuring
the intercorrelations between the items of a scale [45] range
between 0 (weak reliability) and 1 (perfect reliability) and a
cut-off ≥0.7 is commonly used as an indicator of adequate
internal consistency/reliability for research purposes [46].
With regard to the construct validity of the use of a scale
in a specific population, it can be determined by looking at
whether scores are different in groups that should score sig-
nificantly higher or lower on the construct that is supposed to
be measured by the scale (known-groups or extreme groups
technique) [41, 47]. Therefore, the CPMS subscales scores
were compared between different subgroups: participants
who reported suffering versus not suffering from CP, those
who reported knowing versus not knowing someone who
suffers from CP, and those who reported being versus not
being a healthcare professional (Wilcoxon rank-sum tests).
CPMS scores were also compared across sex groups. Finally,
the relation between CPMS scores and participants’ educa-
tion level was assessed by calculating Spearman Correlation
coefficients. All statistical analyses were performed using
IBM SPSS Statistics version 22 and SAS version 9.3.
3. Results
3.1. Participants’ Characteristics. A total of 1958 participants
from the 17 administrative regions of the province of Quebec
completed the web-based questionnaire, among whom 1555
participants answered all the items of the CPMS.The propor-
tion of participants who did not complete all the items of the
CPMS was thus 20.6% and ranged between 16.7% and 24.2%
across the predefined groups of participants (whether they
had CP, knew someone who suffered from CP, or reported
being a healthcare professional). Characteristics of the study
sample are presented in Table 1. Participants’ age varied from
18 to 83 years and 78.4% were women. A total of 69.6%
reported suffering from CP, and 83.6% knew someone who
was suffering from this condition. A minority of participants
(14.5%) reported being a physician, a nurse, a physiotherapist,
a psychologist, or a pharmacist.
3.2. Exploratory Factor Analysis and Item Reduction. The
Kaiser-Meyer-Olkin measure underlined the sampling ade-
quacy (KMO = 0.89) [48]. The initial factor analysis con-
ducted among the 44 preliminary items of the scale revealed
11 different factors that had eigenvalues greater than Kaiser’s
criterion of 1 [48]. However, only 3 factors were retained
based on the scree plot (see Figure 1) which can provide a reli-
able criterion for factor selectionwith a large sample size [48].
These three factors were also in accordance with our a priori
hypothesis that the CPMS would measure three constructs
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Full-time job 772 (50.36)
Part-time job 127 (8.28)
Not working 634 (41.36)
Completed education level
Elementary 15 (0.97)
High school 248 (16.11)
Diploma in vocational studies 201 (13.06)
College/CÉGEP 324 (21.05)
University, undergraduate studies 443 (28.78)
University, graduate studies 308 (20.01)
Region†
Nonremote regions 1081 (71.35)
Remote resource regions 434 (28.65)
Suffering from CP (pain for ≥ 3 months)
Yes 1070 (69.62)
No 467 (30.38)






∗Proportion of missing data ≤ 2.6%.
∗∗Unless stated otherwise.
†Remote resource regions as defined by Revenu Québec (i.e., the provincial
revenue agency): Bas-Saint-Laurent (region 01), Saguenay–Lac-Saint-Jean
(region 02), Abitibi-Témiscamingue (region 08), Côte-Nord (region 09),
Nord-du-Québec (region 10), and Gaspésie–Îles-de-la-Madeleine (region 11).
Nonremote regions are near major urban centres.
††Physician, nurse, physiotherapist, psychologist, or pharmacist.
CP: chronic pain; SD: standard deviation.
of knowledge, beliefs, and attitudes, that is, those towards
people suffering fromCP, its biopsychosocial impacts, and its
treatment. Based on the rotated factor matrix, items present-
ing loadings that rounded below 0.4 [48] on all three factors
were removed from the analysis. Table 2 shows the final
factor loadings after rotation. The items that clustered on the
same factors suggest that factor 1 best represents knowledge,


























Figure 1: Scree plot.
(9 items), factor 2 knowledge, beliefs, and attitudes towards
biopsychosocial impacts of CP (10 items), and factor 3 knowl-
edge, beliefs, and attitudes towards treatment of CP (7 items);
96.15% of the items showed no crossloading (item loads≥0.32
on two or more factors [44]). The final version of the CPMS
thus contained 26 items. Descriptive statistics and floor and
ceiling effects for each of the CPMS subscales are presented in
Table 2. Less than 16% of participants achieved the lowest or
highest possible scores, respectively, which can be considered
acceptable [49].
3.3. CPMS’s Internal Consistency. Cronbach’s 𝛼 coefficients
for each of the three CPMS subscales are shown at the bottom
of Table 2 (𝛼 = 0.72–0.82). All the 𝛼 values reached the 0.7
cut-off suggesting adequate reliability of the CPMS subscales.
The same was true among participants suffering (𝛼 = 0.72–
0.78) versus not suffering from CP (𝛼 = 0.72–0.85), those
who reported knowing (𝛼 = 0.72–0.81) versus not knowing
someonewho suffers fromCP (𝛼= 0.69–0.83), and thosewho
reported being (𝛼 = 0.73–0.79) versus not being a healthcare
professional (𝛼 = 0.70–0.82).
3.4. CPMS’s Construct Validity. Comparisons of CPMS sub-
scales scores between the predefined groups of participants
are presented in Figure 2. Statistically significant group
differences (𝑝 < 0.05) were found, the CPMS scores being
higher on average among participants who reported suffering
from CP (2/3 subscales), in those who knew someone who
suffered from CP (3/3 subscales), and in those who were a
healthcare professional (2/3 subscales). The only exceptions
were regarding the first subscale (knowledge, beliefs, and
attitudes regarding people suffering from CP), where no
difference was found between participants reporting being
versus not being a healthcare professional (𝑝 = 0.8770), and
the third subscale (knowledge, beliefs, and attitudes regard-
ing treatment of CP), where the score was higher among
participants not suffering from CP (𝑝 = 0.0002). Differences
were also found between women and men, with women pre-
senting higher scores on the three CPMS subscales (people
suffering from CP subscale: 40.22 ± 4.24 versus 38.94 ± 4.44;




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































p < 0.0001 p = 0.0055 p = 0.8770 p = 0.0016 p < 0.0001 p < 0.0001

































































































































































































Figure 2: Comparison of CPMS subscales scores between different subgroups of participants. ∗Higher scores indicate higher knowledge and
more positive beliefs and attitudes towards CP, its biopsychosocial impacts, and its treatment. The numbers in brackets refer to the range of
possible scores for each of the three subscales. CPMS: Chronic Pain Myth Scale.
biopsychosocial impacts of CP subscale: 41.87 ± 4.77 versus
40.83 ± 5.00; treatment of CP subscale: 27.36 ± 4.25 versus
26.81 ± 4.36; all𝑝 < 0.05). Statistically significant correlations
were also found between CPMS scores and the education
level of participants (people suffering from CP subscale: 𝑟 =
−0.13; biopsychosocial impacts of CP subscale: 𝑟 = 0.06;
treatment of CP subscale: 𝑟 = 0.25; all 𝑝 < 0.05).
4. Discussion
Many scales are presently available to measure perceptions
towards pain. However, none of these scales were specifically
designed to be broadly used in the community whether the
person suffers or not from CP or is a healthcare professional
or not. This study thus aimed at developing such a type of
scale tomeasure knowledge, beliefs, and attitudes people have
towards persons having CP, the biopsychosocial impacts of
this type of disorder, and its treatment. The results of our
study, which was carried out in French-speaking individuals
in the province of Quebec, provide preliminary insights into
the psychometric qualities of the use of the CPMS in terms
of internal structure, internal consistency, and construct
validity.
Careful attention was given to the different steps of the
CPMS development in order to maximize its content validity
(i.e., the extent to which the scale measures all relevant
content or domains of the topic it is supposed tomeasure [41])
and its internal structure.All estimated coefficients of internal
consistency of the CPMS subscales showed adequate reliabil-
ity (𝛼 > 0.7) which supports its use for research purposes in
large populations [46]. Whether the participants were suffer-
ing from CP did not alter the CPMS reliability statistics.
Using the known-groups technique, preliminary argu-
ments towards the construct validity of the use of the CPMS
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are also provided; that is, the majority of CPMS scores
revealed better knowledge and more positive attitudes in
groups that were expected to score higher on the scale such as
patients having CP and participants who knew someone who
suffered from CP.These results are consistent with validation
studies of other scales used to survey knowledge, beliefs, and
attitudes about pain which reported significantly different
scores between pain patients and pain-free controls [35, 38,
40]. No difference regarding the knowledge, beliefs, and atti-
tudes regarding people suffering fromCP subscale was found
between participants reporting being versus not being a
healthcare professional.This result is not surprising consider-
ing that several studies reported on stigmatization of patients
suffering from CP from healthcare professionals [20, 21].
CPMS scores were significantly higher among women
(3/3 subscales) and associated with higher education levels
(2/3 subscales), which also argue in favour of the construct
validity of the scale. In fact, other studies have shown better
knowledge and more positive attitudes regarding chronic
diseases among female participants [26, 50] and more edu-
cated individuals [51, 52]. Effect sizes of bivariate subgroups
analyses were small but could be explained by the fact that
knowledge, beliefs, and attitudes are a multifactorial concept
that cannot be explained by only one variable such as sex or
education level. Although the approaches used in the present
study are informative and necessary, future studies should
however examine other aspects of the CPMS construct
validity such as its ability to predict scores of other validated
tools measuring related constructs.
Considering that the lack of recognition of CP is a barrier
to its optimal management [16, 53], providing a new tool
for the measurement of knowledge, beliefs, and attitudes
towards CP in the community is most useful to better design
and tailor awareness and education programs. That could
ultimately improve CP prevention, recognition, and man-
agement. Besides the computation of CPMS total subscales
scores, individual items of the scale could possibly be used
separately to better describe specific knowledge, beliefs, and
attitudes towards CP.
4.1. Strengths and Limitations. The present study has several
strengths such as its large sample size (in particular for factor
analysis that requires more than 5–20 times more respon-
dents than the number of items to be analyzed [41]), in addi-
tion to the fact that participants had various socioeconomic
profiles and came from different geographic areas of the
province of Quebec, thus maximizing the external validity of
our study. However, it should not be viewed as a population-
based study given the characteristics of our sample (e.g., large
proportion of responders suffering fromCP, large proportion
of women) which may have introduced a participation bias.
In fact, during the study advertising, it was expected that
patients suffering from CP or people who have an interest for
pain would be more inclined to take part in our study. How-
ever, we managed to recruit many individuals that should be
representative of the general public (i.e., neither those who
were suffering from chronic pain nor healthcare profession-
als).
A 5-point Likert scale was chosen for the CPMS. How-
ever, odd-numbered scales present a neutral middle option
(neither agree nor disagree) that could be misinterpreted by
respondents (e.g., do not know). For this reason, we cannot
exclude the possibility that the use of a different number of
points on the Likert scale or even a different scale format
could affect the results. We would note, however, that this
issue did not come out during the expert review or the pretest
of the CPMS. As for the reliability and validity of the CPMS,
other studies should target the full range of psychometric
properties (e.g., confirmatory factor analysis in different val-
idation samples, test-retest reliability, convergent construct
validity, sensitivity to change, and clinically important dif-
ferences). Moreover, reliability and validity are not fixed
psychometric properties of a scale and are unique to its
use for a given patient population [41]. For this reason, we
cannot assume that the psychometric properties assessed in
our study will be exactly the same in other populations or in
smaller studies.
5. Conclusion
Globally, the results of this study suggest that the CPMS
could be a valuable general-purpose tool for research among
French-speaking populations of the province of Quebec.This
new scale could be useful to better describe knowledge,
beliefs, and attitudes of the general public that could help
to design successful awareness and education activities about
the importance of CP, its impacts, and the ways to prevent
it. Next steps would be to report on additional psychometric
properties of the CPMS, which could eventually be used
to help generate evidence supporting benefits of education
programs, awareness campaigns, and stigma-reduction activ-
ities.
Appendix
Échelle des Connaissances, Attitudes et
Croyances de la Population envers la Douleur
Chronique, Ses Impacts et Son Traitement
Les énoncés suivants portent sur votre perception des gens
qui souffrent de douleur chronique.
Veuillez indiquer dans quelle mesure vous êtes d’accord
avec ces énoncés sur une échelle allant de “Pas du tout
d’accord” à “Tout à fait d’accord”.
Les gens qui souffrent de douleur chronique...
(1) Ont vraiment mal, ce n’est pas dans leur tête.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
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(2) Veulent juste se faire prescrire des médicaments.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(3) Cherchent à obtenir des congés de maladie pour ne
plus travailler.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(4) Veulent juste paresser et ne pas accomplir leurs tâches
quotidiennes.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(5) Se plaignent de douleurs pour obtenir de l’attention
de la part des autres.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(6) Veulent vraiment aller mieux.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(7) Se plaignent de leur douleur, mais continuent leurs
activités (p.ex., sports, motoneige). Leur douleur ne
doit pas être si pire que ça.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(8) Deviennent dépendants à leursmédicaments (comme
des toxicomanes).
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(9) Ont souvent tendance à exagérer la sévérité de leur
condition.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
Les énoncés suivants portent sur votre perception des impacts
de la douleur chronique.
Veuillez indiquer dans quelle mesure vous êtes d’accord
avec ces énoncés sur une échelle allant de “Pas du tout
d’accord” à “Tout à fait d’accord”.
(10) La douleur chronique provoque plusieurs symptômes
physiques (p.ex., tensions musculaires, modification
de l’appétit, réduction de la mobilité, fatigue).
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(11) La douleur chronique peut avoir un effet direct sur la
vie sexuelle.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(12) Les gens souffrant de douleur chronique sont parfois
rejetés par leurs proches.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(13) La douleur chronique peut s’accompagner d’émotions
négatives (p.ex., peur, colère ou tristesse).
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
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(14) Les gens souffrant de douleur chronique n’ont pas
tendance à s’isoler.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(15) Les gens souffrant de douleur chronique ont
généralement plus de difficulté à résister aux
événements stressants de la vie quotidienne.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(16) Les risques de décès par suicide sont plus élevés chez
les gens atteints de douleur chronique que dans la
population générale.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(17) La douleur chronique coûte des milliards de dollars à
notre société.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(18) Les gens souffrant de douleur chronique n’ont pas
toujours accès aux services de santé pour les soigner.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(19) Les médecins manquent de temps pour traiter les cas
de douleur chronique.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
Les énoncés suivants portent sur votre perception des traite-
ments pour la douleur chronique.
Veuillez indiquer dans quelle mesure vous êtes d’accord
avec ces énoncés sur une échelle allant de “Pas du tout
d’accord” à “Tout à fait d’accord”.
(20) Consulter un psychologue ne sert à rien, sauf si la per-
sonne souffrant de douleur chronique est déprimée.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(21) Il n’y a pas grand-chose à faire pour améliorer la
douleur chronique.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(22) De bonnes habitudes de sommeil contribuent à
réduire la douleur chronique.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(23) Une alimentation équilibrée contribue à réduire la
douleur chronique.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
◻ Tout à fait d’accord
(24) Faire de l’exercice physique risque d’aggraver la
douleur chronique.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
(25) Travailler risque d’aggraver la douleur chronique.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
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◻ D’accord
∗
◻ Tout à fait d’accord
(26) Le traitement de la douleur chronique c’est entre les
mains des professionnels de la santé et non celles du
patient.
◻ Pas du tout d’accord
◻ Pas d’accord
◻ Ni d’accord, ni en désaccord
◻ D’accord
∗
◻ Tout à fait d’accord
Calcul des Scores. Les scores sont obtenus en effectuant la
somme des items propres à chacune des dimensions:
(1) Connaissances, attitudes et croyances en regard
des personnes qui souffrent de douleur chronique
(somme des items (1) à (9)).
(2) Connaissances, attitudes et croyances en regard des
impacts de biopsychosociaux de la douleur chronique
(somme des items (10) à (19)).
(3) Connaissances, attitudes et croyances en regard du
traitement de la douleur chronique (somme des items
(20) à (26)).
Accorder des points s’étendant de 1 pour la réponse “Pas du
tout d’accord” à 5 pour la réponse “Tout à fait d’accord”.
Pour les items formulés négativement∗, inverser les scores
lors des analyses afin qu’un score total plus élevé corresponde
à une meilleure connaissance ainsi que des attitudes et
croyances plus positives envers la douleur chronique, ses
impacts et son traitement.
Additional Points
Summary. This study aimed at developing and validating the
Chronic Pain Myth Scale (CPMS), a French-Canadian scale
for the measurement of knowledge, beliefs, and attitudes of
people in the community towards individuals suffering from
chronic pain (CP), biopsychosocial impacts of CP, and
treatment of CP.The results of this web-based cross-sectional
study conducted among the Quebec population provide
preliminary evidence suggesting that the CPMS could be a
valuable tool for research among French-speaking popula-
tions.
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